Home J Young Pharm, Vol 14/Issue 4/2022 Multisystem Inflammatory Syndrome in Adults (MIS-A): A Case Report

Multisystem Inflammatory Syndrome in Adults (MIS-A): A Case Report

by [email protected]
Published on: October 2022
Journal of Young Pharmacists, 2022; 14(4):449-450
Case Report | doi:10.5530/jyp.2022.14.92
 
Authors:

Nikhil Batra1, Navneet Kaur2,*

1Department of General Medicine, Maharishi Markandeshwar Institute of Medical Science and Research, Ambala, Haryana, INDIA.

2University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, INDIA.

Abstract:

The Severe Acute Respiratory Syndrome (SARS-CoV-2) pandemic has reverberated into calamitous illness globally, even though children have been comparatively reprieved. Coronavirus-associated multisystem inflammatory syndrome (MIS) has been outlined in children (MIS-C) and hardly ever in adults (MIS-A) in as much as April and June 2020, sequentially. Whilst the rudimentary immunopathology is not well demarcated, adaptive immunity is contemplated to be blameworthy. We report a case of Multisystem inflammatory syndrome in children lie illness – MIS-A who presented with fever, pain abdomen, weakness and low oxygen saturation in an emergency. Truenat for SARS-CoV-2 came out negative but covid serology IGG came positive. The clinical presentation of the patient was in maintained with the clinically accepted definition of MIS-A.

Keywords: Coronavirus, Multisystem inflammatory syndrome in adults, Severe acute respiratory syndrome.